Chorea and seizures in a patient with a rare VPS13A gene mutation and neuroacanthocytosis
Vignesh Anapathur Srinivasan1, Jeevitha Moorthy1, Kanagasabai Kamalasekar2
1Neurology, Kauvery Hospital Chennai, Chennai, Tamil Nadu, India.
Insights
Choreo-acanthocytosis, a rare neurodegenerative disorder, is detailed in this case report. Genetic testing identified a VPS13A mutation, highlighting the importance of genetic analysis for atypical movement disorders.
Area of Science:
- Neurogenetics
- Movement Disorders
- Neurodegenerative Diseases
Background:
- Choreo-acanthocytosis (hAc) is an autosomal-recessive neurodegenerative disorder.
- It typically presents with movement abnormalities, seizures, and behavioral changes.
Purpose of the Study:
- To report a case of Choreo-acanthocytosis in a male patient with progressive movement disorder, seizures, and cognitive decline.
- To emphasize the diagnostic challenges, differential diagnoses, and the role of genetic testing in atypical movement disorders.
- To expand the understanding of the VPS13A gene's mutational spectrum and clinical variability.
Main Methods:
- Clinical case presentation.
- Neurological examination and neuroimaging.
- Routine metabolic and infectious investigations.
- Genetic testing for VPS13A variants.
Main Results:
- The patient exhibited progressive movement disorder, seizures, and cognitive impairment.
- Neuroimaging suggested basal ganglia degeneration.
- Genetic analysis revealed a likely pathogenic VPS13A variant (c.799C>T, p.Arg267Ter).
Conclusions:
- This case underscores the complexity of diagnosing Choreo-acanthocytosis.
- Genetic testing is crucial for identifying rare mutations like VPS13A in atypical movement disorders.
- The VPS13A mutation significantly impacts patient quality of life and expands the known clinical presentations of hAc.
Abstract:
Choreo-acanthocytosis (hAc) is an autosomal-recessive, neurodegenerative disorder, often presenting as movement disorder, seizures and behavioural changes. This case report describes a male patient who presented with progressive movement disorder, long-standing seizures and cognitive impairment. Neurological examination and neuroimaging revealed features suspicious for basal ganglia degeneration. Routine metabolic and infectious investigations were negative. Genetic testing identified a likely pathogenic VPS13A variant (c.799C>T, p.Arg267Ter), a rare genetic mutation associated with ChAc. This report highlights the complexities of diagnosis, differential considerations, the importance of genetic testing in atypical movement disorders, therapeutic strategies,and the detrimental impact of the VPS13A gene mutation on the patient's quality of life. This case also tries to expand the known mutational spectrum of the VPS13A gene and its varied clinical presentation.
More Related Videos
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Lysosomal Hydrolases
Inborn Errors of Metabolism
Parkinson's Disease: Overview


